glp-1 hfpef 🔴GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes & HFpEF⤵️ 🔹GLP-1RA use is associated with improved cardiovascular outcomes in non-obese patients with T2DM and and has an associated incremental benefit SGLTi and GLP-1 in HF

Semaglutide GLP-1 is a highly effective option for those struggling with weight loss, Ozempic is a brand name of semaglutide GLP-1 that was originally approved to help manage type 2 diabetes

In some cases, pharma patient-support portals have API links to ePA solutions: when a patient enrolls in a manufacturer program, they can trigger an ePA message with the required financial assistance details attached

GLP-1 short-term side effects include: Nausea Vomiting Diarrhea Constipation Headaches Fatigue Dizziness GLP-1 long-term side effects include: Ongoing and persistent irregular bowel movements Sluggish digestion Changes in gut comfort over time Impact on bone health and density Reduction in muscle mass Nutritional deficiencies Its important to note that long-term GLP-1 medication side effects have not been well-studied

Dehydration commonly produces symptoms including fatigue, headache, dizziness, muscle weakness, and general malaise, which patients may interpret as flu-like